Accordingly, the stable knockdown of KEAP1 was also found to enhance while NRF2 silencing repressed the expression of TKT in HCC cells, wherein this enzyme promoted NADPH synthesis, tumor growth, metastasis formation and sorafenib resistance [154]. The gene discussed is KEAP1; the disease is hepatocellular carcinoma.